Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Arthritis, Rheumatoid × Chloroquine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Glioblastoma 4 Small Cell Lung Carcinoma 1 Pancreatic Neoplasms 1 Pancreatic Cancer Metastatic 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lung Neoplasms 1 Gliosarcoma 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms 1 Brain Neoplasms 1 Arthritis, Rheumatoid 1

Interventions

Methotrexate 10 Etanercept 10 Adalimumab 10 Abatacept 5 tocilizumab 4 Rituximab 4 tofacitinib 3 olokizumab 3 golimumab 3 Infliximab 3 Tumor Necrosis Factor Inhibitors 2 Saline Solution 2 RC-18 2 Nivolumab 2 Leflunomide 2 Certolizumab Pegol 2 Antirheumatic Agents 2 veltuzumab 1 upadacitinib 1 secukinumab 1 sarilumab 1 mavrilimumab 1 entecavir 1 baricitinib 1 andecaliximab 1 Vitamin D 1 Vaccines 1 Syringes 1 Sulfasalazine 1 Specimen Handling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03449758 2022-04-28

SariPRO

Sanofi

Phase 4 Completed

84 enrolled 36 charts

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡